Manager to step down next April
Country still has plenty to offer
Araminta Le Flufy set to become CEO
Board sets out further consultation period to 14 October
Addressing 'leading global challenges of our time'
Promoting greater dialogue with shareholders
Improving clarity over corporate pay
Tightening of profit-making rules
With great power comes great responsibility. As ESG momentum intensifies, the scrutiny over the pharmaceutical sector’s role in society is increasing. How 'pharma' evolves to meet fresh ESG challenges will present challenges and opportunities for the...